The 19 billion-dollar startups to watch that are revolutionizing healthcare in 2020
- 2019 was a critical year for biotech and healthcare startups, with an unprecedented number making the leap from private to public, and more considering making the jump in 2020.
- There are 19 healthcare startups that have reached unicorn status, or the $1 billion and over valuation mark, according to PitchBook and Business Insider's reporting.
- Some like Bright Health and Clover Health added hundreds of millions to their war chests in 2019, while others didn't take on additional funding in the last year. Here's what to know about the companies going into 2020.
- Subscribe to Dispensed, Business Insider's weekly healthcare newsletter.
- Click here for more BI Prime stories.
2020 is gearing up to be a pivotal year for healthcare and biotech startups.
In 2019, a handful of health startups went public with valuations above $1 billion, placing them in unicorn territory.
2020 is shaping up to be an even more prolific year, with reports that companies like One Medical could go public by the first quarter of 2020.
While companies like Tempus, Ginkgo Bioworks and health insurance startups Clover Health and Bright Health added to their war chests, others like 23andMe and Butterfly Network maintained their unicorn status without taking on additional funding, according to data provided by PitchBook.
Clarrie Feinstein contributed to a previous version of this post.
Featured Digital Health Articles:
- Telehealth Industry: Benefits, Services & Examples
- Value-Based Care Model: Pay-for-Performance Healthcare
- Senior Care & Assisted Living Market Trends
- Smart Medical Devices: Wearable Tech in Healthcare
- AI in Healthcare
- Remote Patient Monitoring Industry: Devices & Market Trends